LTR Pharma Operating Income Over Time
| LTP Stock | 0.49 0.02 3.92% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LTR Pharma Performance and LTR Pharma Correlation. LTR |
Cross Equities Operating Income Analysis
Compare LTR Pharma and related stocks such as Rand Mining, Marimaca Copper Corp, and Strickland Metals Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RND | 3.5 M | 5.8 M | 12 M | 5.1 M | 7.5 M | 15.8 M | 16.4 M | 19.9 M | 35.3 M | (2.1 M) | 24.2 M | 17 M | 15.1 M | 10.3 M | 28.6 M | 32.9 M | 34.5 M |
| MC2 | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (17.2 M) | (6.8 M) | (5.9 M) | (11.3 M) | (13 M) | (13.7 M) |
| STK | (162.7 K) | (732.3 K) | (1.1 M) | (578.5 K) | (2.9 M) | (554.1 K) | (782.7 K) | (462.5 K) | (1.9 M) | (733.4 K) | (3.9 M) | (4.2 M) | (2.2 M) | (4 M) | 1.6 M | 1.4 M | 1.5 M |
| PFT | (8 M) | (1.8 M) | (14.9 M) | (44.6 M) | (13.6 M) | (63.9 M) | (55 M) | (376.3 M) | (1.2 M) | (211 K) | (1.1 M) | (2.9 M) | (1.6 M) | (2.6 M) | (2.9 M) | (2.6 M) | (2.7 M) |
| RFG | 10.2 M | 46.7 M | 51.7 M | 55.8 M | 58.1 M | 85.7 M | 90.5 M | (39 M) | (92.2 M) | (10.8 M) | 9 M | 2.2 M | (13.2 M) | (1.9 M) | 4.5 M | 4.1 M | 3.9 M |
| TRM | (296.9 K) | (454.2 K) | (576 K) | (378.1 K) | (410.2 K) | (315.1 K) | (281.2 K) | (318.5 K) | (129.7 K) | (264.7 K) | (369.2 K) | (325.3 K) | (515 K) | (417.7 K) | (184.7 K) | (212.4 K) | (223.1 K) |
LTR Pharma and related stocks such as Rand Mining, Marimaca Copper Corp, and Strickland Metals Operating Income description
Operating Income is the amount of profit realized from LTR Pharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of LTR Pharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| LTR Pharma | LTP |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 2997 Creek Street, |
| Exchange | Australian Securities Exchange |
null 0.49
Additional Tools for LTR Stock Analysis
When running LTR Pharma's price analysis, check to measure LTR Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LTR Pharma is operating at the current time. Most of LTR Pharma's value examination focuses on studying past and present price action to predict the probability of LTR Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LTR Pharma's price. Additionally, you may evaluate how the addition of LTR Pharma to your portfolios can decrease your overall portfolio volatility.